Future Virology
Future Virology is a journal indexed in SJR in Virology with an H index of 48. It has a price of 2395 €. It has an SJR impact factor of 0,361 and it has a best quartile of Q3. It has an SJR impact factor of 0,361.
Metrics
Scimago and CountryOfPapers database fields
SJR Impact
0,361
H-index
48
Docs (year)
46
Docs 3y
279
Total refs
2480
Cites 3y
367
Citable 3y
256
Cites/Doc 2y
1.39
Ref/Doc
53.91
Immediate OA
2395 €
Embargoed OA
NPD
Non OA / Submission
0 €
Name good journals. Call out predatory ones.
Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.
Researcher reviews
Best articles by citations
Characteristics of viral IL-10 gene in Epstein-Barr virus infection in children in China
View moreVirus and noncoding RNAs: stars in the host-virus interaction game
View moreEBV glycoproteins: where are we now?
View moreCurrent and future targets of antiviral therapy in the hepatitis C virus life cycle
View moreCould inhibiting IL-8 enhance HBV IFN-a treatment?
View moreCould boosting the oligoadenylate synthetase-like pathway bring a new era of antiviral therapy?
View moreCorneal latency and transmission of herpes simplex virus-1
View moreControversies in 21st century virology
View moreConformational analysis of hepatitis B virus surface antigen mutations among HIV-positive patients diagnosed with occult hepatitis B virus
View moreComparison of renal changes with lopinavir/ritonavir plus raltegravir or tenofovir/emtricitabine in the PROGRESS study
View moreCommunity-associated methicillin-resistantStaphylococcus aureusand HIV
View moreCombating Japanese encephalitis: Vero-cell derived inactivated vaccines and the situation in Japan
View moreCharacterization and risk of blood-borne virus transmission in organ transplantation: what are the priorities?
View moreA closed-handed affair: positive-strand RNA virus polymerases
View moreCD8 T-cell response to respiratory syncytial virus infection
View moreCardiovascular risk prediction in patients with HIV infection
View moreCandidate medical countermeasures targeting Ebola virus cell entry
View moreCan the HPV vaccine prevent more than cervical cancer? An epidemiologic perspective
View moreCan the ever-promising target HIV reverse transcriptase-associated RNase H become a success story for drug development?
View moreCan an influenza A-based delivery system overcome current challenges associated with miRNA technology?
View moreArboviruses: variations on an ancient theme
View moreApoptosis and autophagy as a turning point in viral-host interactions: the case of human norovirus and its surrogates
View moreAntiviral and inflammatory crosstalk in the control of RNA virus infection
View moreAlbumin-interferon-a in the treatment of chronic hepatitis C
View more